Arnold Lippa insider trades: Hepion Pharmaceuticals (HEPA) SEC Form 4 filings
Companies
Where Arnold reports to the SEC
Other HEPA insiders
Open-market trades in the last 12 months
About Arnold Lippa's insider trades
Arnold Lippa is a director at Hepion Pharmaceuticals (HEPA). Arnold has not reported an open-market purchase or sale.
Their filings also include grants and awards (14 filings), other transactions (11 filings), gifts (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HEPA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.